MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
Taysha Gene Therapies, Inc. Common Stock

TSHA

#1816
Taysha Gene Therapies, Inc. Common Stock
4.53
+0.44%
Sector:
Base:
Profit Currency:
Daily Range
4.53
4.53
Year Range
1.05
6.02
Daily Change
+0.44%
Monthly Change
-4.43%
6 month change
+51.51%
Year Change
+177.91%
Previous Close
4.51
Open
4.53
Bid
Ask
Low
4.53
High
4.53
Volume
115
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. TSHA
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value 20202021202220232024 TTM

News

Investing Investing
TSHA NGNE
2026.01.12
Stifel reiterates Buy rating on Neurogene stock, cites viable safety margin
Investing Investing
TSHA
2026.01.06
Taysha doses first patient in pivotal Rett syndrome gene therapy trial
Investing Investing
TSHA
2025.12.24
Taysha Gene Therapies stock hits 52-week high at $5.98
Investing Investing
SLDB DNTH ORIC TNGX TSHA
2025.12.24
Biotech Stocks: Jefferies Names its 6 Top Picks for 2026
Investing Investing
NGNE TSHA
2025.12.17
Citizens reiterates Market Outperform rating on Taysha Gene Therapies stock
Investing Investing
TSHA
2025.12.08
Taysha Gene Therapies stock hits 52-week high at 5.51 USD
Investing Investing
TSHA
2025.12.04
Goldman Sachs upgrades Taysha Gene Therapies stock rating to Buy
Investing Investing
TSHA
2025.12.02
Nagendran Sukumar sells Taysha gene therapies (TSHA) shares for $1.69m
Investing Investing
NGNE TSHA
2025.11.14
Cantor Fitzgerald maintains Overweight rating on Taysha Gene Therapies stock
Investing Investing
NGNE TSHA
2025.11.13
Neurogene stock price target raised to $70 from $65 at H.C. Wainwright
Investing Investing
TSHA
2025.11.05
Taysha Gene Therapies stock price target raised to $8 at Citizens
Seeking Alpha Seeking Alpha
TSHA
2025.11.04
Taysha Gene Therapies, Inc. (TSHA) Q3 2025 Earnings Call Transcript

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Market
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd